Background: Antiretroviral regimens aim to achieve undetectable HIV-1 RNA <50 copies/mL (c/mL). Below 50 c/mL, the Amplicor HIV-1 RNA v1.5 assay provides qualitative results, either “< 50 c/mL (ie, HIV-1 RNA detected but not quantified), or “<50 c/mL, No HIV-1 RNA Detected”, referred to as “target not detected” (TND). Efficacy and TND of three first-line INSTI, NNRTI, and PI-based regimens in two phase 3 randomized, double-blinded clinical trials in HIV-1-infected, treatment-naive adults were explored. Methodology: Study 102: Elvitegravir/cobicistat/emtricitabine/tenofovir DF (EVG/COBI/FTC/TDF) vs. efavirenz/FTC/TDF (EFV/FTC/TDF); Study 103: EVG/COBI/FTC/TDF vs. ritonavir-boosted atazanavir with FTC/TDF (ATV+RTV+TVD). Plasma HIV-1 RNA levels were assessed at all study visits through Week (W) 144 using the Roche COBAS Amplicor HIV-1 Monitor Test v1.5. All subjects in the ITT population from both studies were evaluated (n=1,408). Achievement of TND by treatment group and baseline characteristics was evaluated. P-values by two-sided Fisher’s Exact Test < 0.05 were statistically significant. Results: Statistically more EVG/COBI/FTC/TDF subjects achieved TND than EFV/FTC/TDF from W2-W16 and from W2-W24 for ATV+RTV+TVD. However, after these time periods, TND levels were similar between treatment groups through W144 (Table 1). TND at W144 for all treatment groups was more frequent in subjects with baseline HIV-1 RNA ≤100,000 copies/ml and having adherence ≥95%. Consistent and reproducible TND results were achieved and maintained at all visits from W48-W144 in approximately 15% of patients regardless of treatment group. Conclusions: Subjects treated with EVG/COBI/FTC/TDF achieved HIV-1 RNA TND more rapidly than those treated with EFV/FTC/TDF or ATV+RTV+TVD. By W48 and through W144, TND was similar for all treatment groups. The clinical significance of achieving TND is uncertain. TND was associated with early initiation of treatment as suggested by lower HIV-1 RNA, consistent with recent treatment initiation guideline recommendations.